Courtney Breen
Stock Analyst at Bernstein
(4.50)
# 1,051
Out of 4,575 analysts
299
Total ratings
87%
Success rate
18.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Courtney Breen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMGN Amgen | Maintained: Hold | $335 | $376.04 | -10.91% | 30 | Jul 22, 2026 | |
| BMY Bristol-Myers Squibb Company | Maintained: Hold | $58 | $62.09 | -6.59% | 31 | Jul 22, 2026 | |
| LLY Eli Lilly and Company | Maintained: Buy | $1,385 | $1,196.03 | +15.80% | 60 | Jul 22, 2026 | |
| GILD Gilead Sciences | Maintained: Buy | $160 | $129.31 | +23.73% | 30 | Jul 22, 2026 | |
| MRK Merck & Co. | Maintained: Hold | $100 | $131.07 | -23.70% | 39 | Jul 22, 2026 | |
| PFE Pfizer | Maintained: Hold | $30 | $24.54 | +22.25% | 38 | Jul 22, 2026 | |
| ABBV AbbVie | Maintained: Hold | $225 | $259.36 | -13.25% | 29 | Jul 22, 2026 | |
| MRNA Moderna | Maintained: Hold | $45 | $54.07 | -16.77% | 41 | Jul 22, 2026 | |
| LON: 0QIU Novo Nordisk A/S | Maintained: Sell | kr 175.00 | kr 320.60 | -45.41% | 1 | May 12, 2026 |
Amgen
Jul 22, 2026
Maintained: Hold
Price Target: $335
Current: $376.04
Upside: -10.91%
Bristol-Myers Squibb Company
Jul 22, 2026
Maintained: Hold
Price Target: $58
Current: $62.09
Upside: -6.59%
Eli Lilly and Company
Jul 22, 2026
Maintained: Buy
Price Target: $1,385
Current: $1,196.03
Upside: +15.80%
Gilead Sciences
Jul 22, 2026
Maintained: Buy
Price Target: $160
Current: $129.31
Upside: +23.73%
Merck & Co.
Jul 22, 2026
Maintained: Hold
Price Target: $100
Current: $131.07
Upside: -23.70%
Pfizer
Jul 22, 2026
Maintained: Hold
Price Target: $30
Current: $24.54
Upside: +22.25%
AbbVie
Jul 22, 2026
Maintained: Hold
Price Target: $225
Current: $259.36
Upside: -13.25%
Moderna
Jul 22, 2026
Maintained: Hold
Price Target: $45
Current: $54.07
Upside: -16.77%
Novo Nordisk A/S
May 12, 2026
Maintained: Sell
Price Target: kr 175.00
Current: kr 320.60
Upside: -45.41%